Connect with us

EU

Excessive corporate influence over policy-making remains threat, says #ALTER-EU

Published

on

Excessive corporate influence over policy-making remains a serious threat to the public interest across Europe and at the EU level, warns a new report published by the Alliance for Lobbying Transparency and Ethics Regulation in the EU (ALTER-EU).

Whether avoiding regulation or increasing public funding for corporate activities: lobbying; the revolving door between business and politics; strategic pitches of corporate ‘expertise’; as well as privileged access to decision-makers and corporations’ threats to leverage their structural economic power continue to be highly effective tools used by big business to ensure decision-makers prioritise the profit interests of corporations over vital public needs.

The report includes eight case studies from the EU level and member states showing where the influence of corporations has been so extensive that it constitutes corporate capture. The cases have been investigated and written by NGOs and researchers around Europe. They touch upon various areas of policy-making, including:

  • Financial policy (EU level): a banking industry that has mostly managed to avoid stricter regulation despite causing a gigantic financial crisis with devastating economic consequences,
  • Security policy (EU level): an arms industry that has increasingly been setting the agenda and objectives of the EU’s defence programmes, ensuring further militarisation but also increasing the public funding of its lethal business
  • Emissions regulation (DE): Volkswagen’s success in mobilising the German government to cushion any real regulatory fallout from the Dieselgate scandal
  • Corporate taxation (NL): the corporate derailing of plans to tax dividends in the Netherlands at the hands of Shell and Unilever

ALTER-EU coordinator Claudio Cesarano said: Dieselgate and the failure to regulate the financial industry after the crash have clearly shown that the influence of big business often goes beyond simple lobbying, either actively or passively aided by decision-makers. This is an extreme but unfortunately common threat to the public interest, social security, the environment and public health.”

Myriam Douo, campaigner for ALTER-EU member organization Friends of the Earth Europe said: Corporate capture is dangerous for our society. Its devastating consequences can be seen in many different policy areas. Threatening EU standards on public health and the environment through trade agreements, by allowing corporations to avoid paying fair taxes and by exposing citizens to more extreme risks from the financial sector. All of this because corporate profits have been prioritized over the public interest.”

Nina Katzemich, campaigner for ALTER-EU member organization Lobbycontrol, added: The EU Parliament elections are around the corner, so it’s a very good time to put the fight against excessive corporate power firmly on the political agenda. More transparency and stricter ethics rules are important but ultimately, we need a radical change in the way policy-makers at all levels interact with businesses. The needs and demands of citizens must take absolute priority.

  • The Alliance for Lobbying Transparency and Ethics Reform (ALTER-EU) is a coalition of over 200 European NGOs and trade unions.
  • Read Corporate Capture in Europe : When Big Business Dominates Policy-Making and Threatens Our Rights in full here.
  • Short German version here.
  • Hard copies of the report are available on request, please email or call us.
  • Full list of cases studies included in the report:
    - The Banking Sector – Kenneth Haar, Corporate Europe Observatory
    Trade Policy and the Case of TTIP – Paul De Clerck, Friends of the Earth Europe
    The Gas Industry – Myriam Douo, Friends of the Earth Europe

    - Tax Policy in the Netherlands – Jasper van Teeffelen, Lobbywatch
    - The Pharmaceutical Industry – Rachel Tansey, Freelance writer and researcher
    - Data Protection and Privacy Policies - Léa Caillère Falgueyrac, Freelance researcher
    - The Arms Industry - Bram Vranken, Vredesactie
    - Dieselgate and the German Car Industry - Nina Katzemich, Lobbycontrol
  • The publication was launched on 25 September More information here.

coronavirus

EAPM and ESMO bring innovations to health policymakers

Published

on

For the eighth year in succession, the European Alliance for Personalised Medicine (EAPM) has held a high-level conference series alongside the annual ESMO Congress, writes EAPM Executive Director Denis Horgan.

The EAPM conference was opened with the announcement that the following article was published and contributed to by more than 40 experts across the EU on how to bring Greater Accuracy to Europe’s Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.  Please click here to have access.

Sessions include: Session I: Tumor Agnostic, Session II: Biomarkers and Molecular Diagnostics, and Session III: Utilising Real-World Evidence in a health-care setting.  The conference runs from 08.00 – 16.00. Here is the link to the agenda. The conference aims to bring  key recommendations to the EU level, so as to shape the EU Beating Cancer Plan, EU health Data Space, the updating EU Pharmaceutical Strategy as well as the EU Health Union. 

The conference is held following the first State of the Union address by European Commission President Ursula von der Leyen on Wednesday (16 September) – in her first annual address, von der Leyen said the coronavirus pandemic had underlined the need for closer cooperation, stressing that people were “still suffering”.

For me, it is crystal clear – we need to build a stronger European Health Union,” she said. “And we need to strengthen our crisis preparedness and management of cross-border health threats.” Von der Leyen said her commission would try to reinforce the European Medicines Agency and European Centre for Disease Prevention and Control.

And she also raised the importance of the European Beating Cancer Plan as well as European Health Data Space. “This will show Europeans that our Union is there to protect all,” she said.

Fabrice Barlesi, medical director of Gustave Roussy, said: “RCTs are no longer the way to go. A way ahead could be EU support for trialing a new drug and delivering data to a centralised registry, which could give good consolidated data from across Europe.”

Divided into three sessions, the EAPM conference at the ESMO Congress, as mentioned,  dealt with such diverse issues as tumour agnostics, biomarkers and molecular diagnostics and real-world evidence in a health-care setting. Concerning cancer, specifically tumours, the congress stated that  tissue-agnostic cancer drugs are antineoplastic medicines that treat cancers based on the mutations that they display, instead of the tissue type in which they appear.

These drugs include, for example, Entrectinib, Pembrolizumab and Larotrectinib. Former Spanish health minister and MEP Dolors Moseratt highlighted her support for the work of EAPM and looks forward to getting the recommendations of the outcomes from the conference.  “The European added value of health is obvious. It would avoid duplication and enable a better allocation of resources. And it will minimize the risk of fragmented access to therapy across member states.”

And the EAPM conference is at pains to seek the best ways forward for the implementation of Real-World Evidence (RWE) into health care in Europe – looking to find consensus with key decision makers, including at member state level, not least with representatives in the European Parliament, on how to proceed in this area. RWE for health care is a simple concept – harnessing various health data in real time to help make faster and better medical decisions.

Real-World Evidence is an umbrella term for different types of health-care data that are not collected in conventional randomised controlled trials, including patient data, data from clinicians, hospital data, data from payers and social data.

Rosa Giuliani, consultant in medical oncology at the Clatterbridge Cancer Center, said: “Key elements to advance the use of TACs is to conduct dialogue that transcends silos, and to explore re-engineering of the development pathway.” And, as far as biomarkers and molecular diagnostics are concerned, a lot has been said about testing, and often the lack of it, in terms of the COVID-19 outbreak, with different countries adopting different strategies and, also, having different resources when it comes to acquiring necessary kits.

The key focus in the ESMO session was on better and more equitable access to biomarkers and molecular diagnostics across Europe.  This is a must, but, as the attendees acknowledged, we’re a long way short of it. Access to personalised medicine and new diagnostic technologies can help resolve many inefficiencies, such as trial-and-error dosing, the potential for increased hospitalisation time due to adverse drug reactions and the problem of late diagnoses. It may also enhance the effectiveness of therapies through better tailored treatment administration.

In conclusion for the morning session, Giuseppe Curigliano, associate professor of Medical Oncology at the University of Milano, and head of the division of Early Drug Development, at the European Institute of Oncology said: “A real challenge to overcome is the different endpoints between investigators and payers. Policy frameworks and co-operation is essential.” The session in the afternoon will focus on utilizing real-world evidence in a health-care setting.

A report will be available next week. 

Continue Reading

Brexit

EU's Barnier still hopes trade deal with Britain possible, sources say

Published

on

By

The European Union’s Brexit negotiator told the bloc’s 27 national envoys to Brussels that he still hoped a trade deal with Britain was possible, stressing that the coming days would be decisive, diplomatic sources with the bloc told Reuters, write and

Michel Barnier addressed the gathering on Wednesday (16 September) and the three sources either participated in the discussion behind closed doors or were briefed on its content.

“Barnier still believes a deal is possible though the next days are key,” said one of the EU diplomatic sources.

A second diplomat, asked what Barnier said on Wednesday and whether there was still a chance for a new agreement with the UK, said: “The hope is still there.”

The first source said tentative concessions offered by the UK on fisheries - a key point of discord that has so far prevented agreement on a new EU-UK trade deal to kick in from 2021 - were “a glimmer of hope”.

Reuters reported exclusively on Tuesday (15 September) that Britain has moved to break the deadlock despite that fact that publicly London has been threatening to breach the terms of its earlier divorce deal with the bloc.

A third source, a senior EU diplomat, confirmed the UK offer but stressed it was not going far enough for the bloc to accept.

Brexit talks descended into fresh turmoil this month over Prime Minister Boris Johnson’s plans to pass new domestic laws that would undercut London’s earlier EU divorce deal, which is also aimed at protecting peace on the island of Ireland.

US Democratic presidential candidate Joe Biden warned Britain that it must honour the Northern Irish peace deal as it extracts itself from the EU or there would be no US trade deal for the United Kingdom.

The third EU source, who spoke under condition of anonymity, said that the bloc would take a more rigid line in demanding a solid dispute settlement mechanism in any new UK trade deal should Johnson press ahead with the Internal Market Bill.

“There is unease about what Britain is doing but Barnier has stressed he will keep negotiating until his last breath,” said a fourth EU diplomat, highlighting the bloc’s wariness about being assigned blame should the troubled process eventually fail.

Asked about an estimate by Societe Generale bank, which put at 80% the probability of the most damaging economic split at the end of the year without a new deal to carry forward trade and business ties between the EU and the UK, the person said:

“I would put it around the same mark.”

Barnier is due to meet his UK counterpart, David Frost, around 1400 GMT in Brussels on Thursday.

Continue Reading

Brexit

Biden warns UK on #Brexit - No trade deal unless you respect Northern Irish peace deal

Published

on

By

US Democratic presidential candidate Joe Biden warned the United Kingdom that it must honour the Northern Irish peace deal as it extracts itself from the European Union or there would be no US trade deal, write and

“We can’t allow the Good Friday Agreement that brought peace to Northern Ireland to become a casualty of Brexit,” Biden said in a tweet.

“Any trade deal between the US and UK must be contingent upon respect for the Agreement and preventing the return of a hard border. Period.”

Johnson unveiled legislation that would break parts of the Brexit divorce treaty relating to Northern Ireland, blaming the EU for putting a revolver on the table in trade talks and trying to divide up the United Kingdom.

He says the United Kingdom has to have the ability to break parts of the 2020 Brexit treaty he signed to uphold London’s commitments under the 1998 peace deal which ended three decades of sectarian violence in Northern Ireland between pro-British Protestant unionists and Irish Catholic nationalists.

The EU says any breach of the Brexit treaty could sink trade talks, propel the United Kingdom towards a messy exit when it finally leaves informal membership at the end of the year and thus complicate the border between Northern Ireland and EU-member Ireland.

The EU’s Brexit negotiator told the bloc’s 27 national envoys that he still hoped a trade deal with Britain was possible, stressing that the coming days would be decisive, three diplomatic sources told Reuters.

Michel Barnier addressed the gathering on Wednesday and the three sources either participated in the discussion behind closed doors or were briefed on its content.

“Barnier still believes a deal is possible though the next days are key,” said one of the EU diplomatic sources.

Johnson told The Sun that the EU was being “abusive” to Britain and risking four decades of partnership.

He said the UK must “ring-fence” the Brexit deal “to put in watertight bulkheads that will stop friends and partners making abusive or extreme interpretations of the provisions.”

Societe Generale analysts said on Thursday they now see an 80% chance that Britain and the EU will fail to strike a trade deal before the end of the year.

Biden, who has talked about the importance of his Irish heritage, retweeted a letter from Eliot Engel, chair of the Foreign Affairs Committee of the US House of Representatives, to Johnson calling on the British leader to honour the 1998 Good Friday peace deal.

Engel urged Johnson to “abandon any and all legally questionable and unfair efforts to flout the Northern Ireland protocol of the Withdrawal Agreement.”

He called on Johnson to “ensure that Brexit negotiations do not undermine the decades of progress to bring peace to Northern Ireland and future options for the bilateral relationship between our two countries.”

Engel said Congress would not support a free trade agreement between the United States and the United Kingdom if Britain failed to uphold its commitments with Northern Ireland.

The letter was signed by Representatives Richard Neal, William Keating and Peter King.

Johnson is pushing ahead with his plan.

His government reached a deal on Wednesday (16 September) to avert a rebellion in his own party, giving parliament a say over the use of post-Brexit powers within its proposed Internal Market Bill that breaks international law.

Continue Reading
Advertisement

Facebook

Twitter

Trending